0001209191-20-027496.txt : 20200506
0001209191-20-027496.hdr.sgml : 20200506
20200506164343
ACCESSION NUMBER: 0001209191-20-027496
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200504
FILED AS OF DATE: 20200506
DATE AS OF CHANGE: 20200506
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sachdev Amit
CENTRAL INDEX KEY: 0001406338
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 20853244
MAIL ADDRESS:
STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED
STREET 2: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-05-04
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001406338
Sachdev Amit
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
0
1
0
0
EVP, Chief Patient Officer
Common Stock
2020-05-04
4
M
0
32500
109.14
A
67603
D
Common Stock
2020-05-04
4
M
0
9310
131.89
A
76913
D
Common Stock
2020-05-04
4
M
0
1942
86.52
A
78855
D
Common Stock
2020-05-04
4
S
0
1400
258.59
D
77455
D
Common Stock
2020-05-04
4
S
0
6223
259.63
D
71232
D
Common Stock
2020-05-04
4
S
0
8383
260.48
D
62849
D
Common Stock
2020-05-04
4
S
0
4395
261.68
D
58454
D
Common Stock
2020-05-04
4
S
0
9447
262.69
D
49007
D
Common Stock
2020-05-04
4
S
0
964
263.58
D
48043
D
Common Stock
2020-05-04
4
S
0
12940
264.92
D
35103
D
Common Stock
2020-05-05
4
M
0
13356
131.89
A
48459
D
Common Stock
2020-05-05
4
S
0
100
265.72
D
48359
D
Common Stock
2020-05-05
4
S
0
300
267.34
D
48059
D
Common Stock
2020-05-05
4
S
0
700
269.08
D
47359
D
Common Stock
2020-05-05
4
S
0
11553
270.01
D
35806
D
Common Stock
2020-05-05
4
S
0
100
271.09
D
35706
D
Common Stock
2020-05-05
4
S
0
403
272.58
D
35303
D
Common Stock
2020-05-05
4
S
0
200
273.59
D
35103
D
Common Stock
882
I
401(k)
Common Stock
14002
I
GRAT
Stock Option (Right to Buy)
109.14
2020-05-04
4
M
0
32500
0.00
D
2025-02-02
Common Stock
32500
0
D
Stock Option (Right to Buy)
131.89
2020-05-04
4
M
0
9310
0.00
D
2025-07-20
Common Stock
9310
24690
D
Stock Option (Right to Buy)
86.52
2020-05-04
4
M
0
1942
0.00
D
2027-02-02
Common Stock
1942
5825
D
Stock Option (Right to Buy)
131.89
2020-05-05
4
M
0
13356
0.00
D
2025-07-20
Common Stock
13356
11334
D
Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $258.59 (range $258.00 to $258.97).
Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $259.63 (range $259.03 to $260.02).
Open market sales reported on this line occurred at a weighted average price of $260.48 (range $260.05 to $261.04).
Open market sales reported on this line occurred at a weighted average price of $261.68 (range $261.14 to $262.13).
Open market sales reported on this line occurred at a weighted average price of $262.69 (range $262.14 to $263.11).
Open market sales reported on this line occurred at a weighted average price of $263.58 (range $263.17 to $264.02).
Open market sales reported on this line occurred at a weighted average price of $264.92 (range $264.29 to $265.00).
Open market sales reported on this line occurred at a weighted average price of $267.34 (range $267.11 to $267.67).
Open market sales reported on this line occurred at a weighted average price of $269.08 (range $268.76 to $269.53).
Open market sales reported on this line occurred at a weighted average price of $270.01 (range $269.98 to $270.87).
Open market sales reported on this line occurred at a weighted average price of $272.58 (range $272.35 to $272.83).
Open market sales reported on this line occurred at a weighted average price of $273.59 (range $273.50 to $273.67).
Fully vested.
The option vests in 16 quarterly installments from 02/03/2017.
/s/ Sabrina Yohai, Attorney-in-Fact
2020-05-06